DeepMedic Pharma Pte Ltd  ·  UEN 200417298M  ·  SGX Mainboard: DMPH

Company

About DeepMedicPhilosophyCorporate ProfileBoard & OfficersGovernanceNews & Media

Our Business

Business SegmentsQuality & RegulatoryProduct RangeService & Support

Products

Aseptic ProcessingSolid DoseSterilisation & UtilitiesInspection & Digital
Sustainability
Investors
Careers
Contact
124 Lorong 2 Toa Payoh, #08-215, Singapore 310124 +65 6742 8913 info@deepmedicpharma-sg.com

Investor Relations

Audited results, share information and disclosure. Everything material goes to SGXNet first and appears here immediately after.

Share information

DMPH

SGX Mainboard, listed 14 October 2016. Prices are indicative and delayed; the exchange is the authority.

S$5.09Share price30 Jun 2026 · indicative
S$1.62BMarket capitalisation318.4M shares issued
14.2×Price / earningsTrailing twelve months
2.9%Dividend yieldFY2025 · 14.8¢ per share

Five-year record

Audited results.

S$ million except per-share and ratio figures. Years ended 31 December.

 FY2021FY2022FY2023FY2024FY2025
Revenue218.4261.9312.5370.4412.6
Gross profit72.188.5107.4128.9146.5
Gross margin33.0%33.8%34.4%34.8%35.5%
Operating profit26.633.842.852.158.9
Operating margin12.2%12.9%13.7%14.1%14.3%
Profit after tax50.462.979.398.6114.1
R&D expenditure16.820.424.628.931.2
R&D as % of revenue7.7%7.8%7.9%7.8%7.6%
Earnings per share (¢)15.819.824.931.035.8
Dividend per share (¢)6.48.010.212.614.8
Net cash41.258.676.394.8121.4
Order book at year end132.0168.5206.1241.7259.3
Employees7428369481,0721,180

Prepared under Singapore Financial Reporting Standards (International). Full statements, notes and the independent auditor's report are in each year's annual report.

FY2025 segment result

Where the growth came from.

Aseptic Processing Systems drove the year, at +16.6%, on Annex 1-driven fill-finish investment across India, China and South Korea. Solid Dose grew 3.6% against flat regional generics capex — honestly reported, not smoothed.

Segment detail

SegmentFY2025FY2024Change
Aseptic Processing Systems171.2146.8+16.6%
Solid Dose Technologies104.8101.2+3.6%
Sterilisation & Utilities71.467.9+5.2%
Inspection & Digital36.928.1+31.3%
Service, spares & retrofit28.326.4+7.2%
Group412.6370.4+11.4%
Revenue by geographyFY2025Share
Singapore90.822.0%
Greater China94.923.0%
India78.419.0%
Rest of South-East Asia66.016.0%
South Korea & Japan49.512.0%
Rest of world33.08.0%

Shareholding analysis

Substantial shareholders.

HolderCapacityShares (M)%
Tan Wei JieFounder · direct interest92.329.0%
Institutional investor ADeemed interest38.212.0%
Institutional investor BDeemed interest28.79.0%
Founding management (aggregate)Direct interests27.18.5%
Public float131.241.2%
Total issued318.4100%

As at 30 June 2026. Institutional holders are shown generically pending the annual register extract; named disclosure appears in the annual report and in SGXNet filings under Section 137 of the Securities and Futures Act.

Financial calendar

Dates.

Closed periods run for one month before half-year results and two months before full-year results. During a closed period, directors and employees with access to unpublished results may not deal in the company's shares.

Disclosure policy

EventDateStatus
FY2025 full-year results26 February 2026Released
FY2025 Annual Report published31 March 2026Released
FY2025 Sustainability Report published14 April 2026Released
Annual General Meeting28 April 2026Held
FY2025 final dividend payment22 May 2026Paid
1H FY2026 business update19 June 2026Released
1H FY2026 results & analyst briefing13 August 2026Upcoming
Closed period begins (1H FY2026)13 July 2026In effect
3Q FY2026 business update12 November 2026Scheduled
FY2026 full-year results25 February 2027Scheduled

Investor contact

Ask us anything
that is already public.

If it is not public, the answer will be “that would be a disclosure” — and then it becomes one, through SGXNet, for everyone at the same time.

Investor relationsinfo@deepmedicpharma-sg.com
Main line+65 6742 8913
CounterSGX Mainboard · DMPH
Registered office124 Lorong 2 Toa Payoh, #08-215, Singapore 310124
Financial year end31 December